Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lenalidomide

EU orphan designation number: EU/3/11/924   
Active ingredient: Lenalidomide
Indication: Treatment of mantle cell lymphoma
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Centralised Orphan - Designation EMA/OD/078/11 (2011)7901 of 27/10/2011